Taxifolin‐mediated Nrf2 activation ameliorates oxidative stress and apoptosis for the treatment of glucocorticoid‐induced osteonecrosis of the femoral head
Phytotherapy Research · 2024
DOI: 10.1002/ptr.8031 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytotherapy Research, 2024. Verfasst von Hongyi Jiang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China. Hauptthemen laut MEDLINE: Glucocorticoids, Osteonecrosis. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: Medical and Health Technology Program of Zhejiang Province, Wenzhou Municipal Science and Technology Bureau.
Abstract (Originalsprache)
Glucocorticoid‐induced osteonecrosis of the femoral head (GIONFH) is the main complication secondary to long‐term or excessive use of glucocorticoids (GCs). Taxifolin (TAX) is a natural antioxidant with various pharmacological effects, such as antioxidative stress and antiapoptotic properties. The purpose of this study was to explore whether TAX could regulate oxidative stress and apoptosis in GIONFH by activating the nuclear factor erythroid 2‐related factor 2 (Nrf2) pathway. We conducted qRT‐PCR, Western blotting, TUNEL assays, flow cytometry, and other experiments in vitro. Microcomputed tomography analysis, hematoxylin–eosin staining, and immunohistochemical staining were performed to determine the therapeutic effect of TAX in vivo. TAX mitigated the overexpression of ROS and NOX gene expression induced by DEX, effectively reducing oxidative stress. Additionally, TAX could alleviate DEX‐induced osteoblast apoptosis, as evidenced by qRT‐PCR, Western blotting, and other experimental techniques. Our in vivo studies further demonstrated that TAX mitigates the progression of GIONFH in rats by combating oxidative stress and apoptosis. Mechanistic exploration revealed that TAX thwarts the progression of GIONFH through the activation of the Nrf2 pathway. Overall, our research herein reports that TAX‐mediated Nrf2 activation ameliorates oxidative stress and apoptosis for the treatment of GIONFH.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China.
- Key Laboratory of Orthopedics of Zhejiang Province, Wenzhou, China.
- The Second Clinical School of Medicine, Wenzhou Medical University, Wenzhou, China.
ORCID-Profile: Xiaoyun Pan, Xinghe Xue
Förderung
- Medical and Health Technology Program of Zhejiang Province
- Wenzhou Municipal Science and Technology Bureau
Zitieren
APA
Jiang, H., Lin, C., Cai, T., Jiang, L., Lou, C., Lin, S., Wang, W., Yan, Z., Pan, X., & Xue, X. (2024). Taxifolin‐mediated Nrf2 activation ameliorates oxidative stress and apoptosis for the treatment of glucocorticoid‐induced osteonecrosis of the femoral head. Phytotherapy Research. https://doi.org/10.1002/ptr.8031
Vancouver
Jiang H, Lin C, Cai T, Jiang L, Lou C, Lin S, et al. Taxifolin‐mediated Nrf2 activation ameliorates oxidative stress and apoptosis for the treatment of glucocorticoid‐induced osteonecrosis of the femoral head. Phytotherapy Research. 2024. doi:10.1002/ptr.8031
BibTeX
@article{Jiang2024,
author = {Jiang, Hongyi and Lin, Chihao and Cai, Tingwen and Jiang, Liting and Lou, Chao and Lin, Shida and Wang, Weidan and Yan, Zijian and Pan, Xiaoyun and Xue, Xinghe},
title = {Taxifolin‐mediated Nrf2 activation ameliorates oxidative stress and apoptosis for the treatment of glucocorticoid‐induced osteonecrosis of the femoral head},
journal = {Phytotherapy Research},
year = {2024},
doi = {10.1002/ptr.8031}
}
EUVIMED